Skip to content

Effectiveness of high protein supplementation on muscle mass and function among older adults with sarcopenia

Efficacy of high protein supplementation on body composition and muscle function among older adults with sarcopenia: a randomized controlled trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12624000277549
Enrollment
42
Registered
2024-03-18
Start date
2021-12-30
Completion date
2023-07-12
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to investigate the impact of high protein supplement (HPS) on older adults with low muscle mass and muscle function. We hypothesize that HPS consumption for 12 weeks can improve one's muscle mass (assessed using body composition analyzer and MRI) as well as muscle function (assessed through a series of physical tests), when compared to another group of participants who consume placebo supplements. Both researchers and participants will only know which supplements the latter are on after they complete the whole trial.

Interventions

- Participants will be given oral and written instruction by principal researcher on how to consume the high protein supplementation - Type of intervention: high protein supplements - Serving instruction: to dissolve the said supplement in 160ml of lukewarm/cold water, stir well and consume - Supplement content (per sachet): 174kcal, 25.1g protein (whey protein concentrate), 3.0g leucine, 10.2g carbohydrates, 3.1g fat, 2.5g fiber, 10ug vit. D3, 12mcg vit. K - The number of times the intervent

- Participants will be given oral and written instruction by principal researcher on how to consume the high protein supplementation - Type of intervention: high protein supplements - Serving instruction: to dissolve the said supplement in 160ml of lukewarm/cold water, stir well and consume - Supplement content (per sachet): 174kcal, 25.1g protein (whey protein concentrate), 3.0g leucine, 10.2g carbohydrates, 3.1g fat, 2.5g fiber, 10ug vit. D3, 12mcg vit. K - The number of times the intervention will be delivered: 2 sachets daily for 12 weeks - Location of intervention: participant's home - Compliance monitoring: WhatsApp text and/or call will be made to each participant once a week to ensure their compliance

Sponsors

UNO Nutrition Malaysia
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Aged 60 and above Skeletal muscle index (SMI) <7.0kg/m2 (male) or <5.7kg/m2 (female)

Exclusion criteria

Poorly controlled diabetes, chronic kidney disease stage 3a and below, gastrointestinal diseases, milk/soy intolerance or allergy

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026